Pessina Federico, Navarria Pierina, Carta Giulio Alberto, D'Agostino Giuseppe Roberto, Clerici Elena, Nibali Marco Conti, Costa Francesco, Fornari Maurizio, Scorsetti Marta
Department of Neurosurgical Oncology and Neurosurgery, Humanitas Cancer Center and Research Hospital, Rozzano, Milan, Italy.
Department of Radiotherapy and Radiosurgery, Humanitas Cancer Center and Research Hospital, Rozzano, Milan, Italy.
World Neurosurg. 2018 Jul;115:e681-e687. doi: 10.1016/j.wneu.2018.04.136. Epub 2018 Apr 27.
To evaluate the outcome of patients with epidural spinal cord compression from different solid tumors treated with a combined approach, surgery plus radiotherapy (RT), with a follow-up longer than 10 years.
Ninety-seven patients treated between 2002 and 2009 were included. Surgical treatment was performed in patients with good performance status, limited metastatic disease, life expectancy longer than 3 months, and progressive neurologic deficit and/or intractable pain. RT was performed delivering a median total dose of 30 Gy in 10 fractions. Clinical outcome was evaluated using the modified visual analog scale for pain, the Frankel scale for neurologic deficit, and magnetic resonance imaging before treatment, after treatment, and every 3 months thereafter.
Palliative decompression was performed in 27% of patients, tumor curettage (debulking) was performed in 51%, and total vertebrectomy was performed in 22%, followed by RT in 78% of cases. Pain remission was obtained in 98% of patients, and recovery of neurologic function was obtained in 51%. The median follow-up time was 135 months (range, 96-209 months). The 5- and 10-year local control rates were 82.8% and 82.8%, respectively. The median and 5- and 10-year progression-free survival rates were 12 months, 16.9%, and 11.3%, respectively; the median and 5- and 10-year overall survival rates were 18 months, 21.3%, and 12%, respectively. On univariate and multivariate analysis, factors recorded as conditioning survival were the performance status and the presence of other metastases at the time of vertebral treatment (P < 0.01).
Our update confirmed that surgery plus RT is a safe and feasible treatment with limited morbidity. In selected patients with favorable prognostic factors, the combined treatment may significantly impact on survival.
评估采用手术联合放疗(RT)的综合方法治疗不同实体瘤所致硬膜外脊髓压迫患者的结局,随访时间超过10年。
纳入2002年至2009年间治疗的97例患者。对身体状况良好、转移性疾病局限、预期寿命超过3个月、有进行性神经功能缺损和/或顽固性疼痛的患者进行手术治疗。放疗采用中位总剂量30 Gy分10次给予。使用改良视觉模拟疼痛量表、Frankel神经功能缺损量表以及治疗前、治疗后及此后每3个月进行一次的磁共振成像评估临床结局。
27% 的患者进行姑息性减压,51% 进行肿瘤刮除(减瘤),22% 进行全椎体切除术,78% 的病例随后接受放疗。98% 的患者疼痛缓解,51% 神经功能恢复。中位随访时间为135个月(范围96 - 209个月)。5年和10年局部控制率分别为82.8% 和82.8%。中位、5年和10年无进展生存率分别为12个月、16.9% 和11.3%;中位、5年和10年总生存率分别为18个月、21.3% 和12%。单因素和多因素分析显示,记录为影响生存的因素为身体状况以及椎体治疗时其他转移灶的存在(P < 0.01)。
我们的更新研究证实,手术联合放疗是一种安全可行且发病率有限的治疗方法。在具有良好预后因素的特定患者中,联合治疗可能对生存有显著影响。